Hermes Medical Solutions Unveils Cutting-Edge Features in Molecular Imaging
Global, Monday, 19 May 2025.
Hermes Medical Solutions advances global molecular imaging with a new Hermia release, boosting precision in nuclear medicine and joining a project to transform radiopharmaceutical therapy.
Advanced Diagnostic Capabilities
In a significant development announced on May 18, 2025, Hermes Medical Solutions has unveiled new CE-marked functionalities in its Hermia software suite, advancing precision and efficiency in nuclear medicine imaging and dosimetry [1]. The impact of this advancement is already evident at prominent institutions such as Le Centre Hospitalier de l’Université de Montréal (CHUM), where nuclear medicine departments report enhanced efficiency in test readings through the implementation of Hermia software [1].
Strategic Partnership for Radiopharmaceutical Innovation
The company has further strengthened its position in precision medicine by joining the FNIH Biomarkers Consortium’s Precision Dosimetry Imaging Biomarker (PDIB) project [1]. This collaboration aims to revolutionize radiopharmaceutical therapy (RPT) through improved dosimetry methods. The timing of this initiative aligns with broader industry developments in nuclear medicine, as evidenced by the upcoming British Nuclear Medicine Society’s Molecular Radiotherapy Dosimetry Training Sessions scheduled for May 19, 2025 [3].
Educational and Professional Development Initiatives
Hermes Medical Solutions is actively engaging with the professional community through specialized training programs. The company is hosting a SIRT & Dosimetry Clinical Interactive Study Day [1], while maintaining a presence at significant industry events including the Swedish NM Annual Meeting (May 21-23, 2025) and the 43E COLLOQUE ANNU in Bromont, Canada (May 23-25, 2025) [1]. These initiatives coincide with growing industry focus on AI integration in nuclear medicine, as highlighted by upcoming presentations such as Dr. Richard Meades’ discussion on ‘AI in Nuclear Medicine – Current State and Future Trends’ at the BNMS Medical Trainee session [3].